ESC Premium Access

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - Discussion.

Presentation

5 more presentations in this session

Aspirin is out for primary prevention of cardiovascular disease - PRO.

Speaker: Professor J. Armitage (Oxford, GB)

Thumbnail

Aspirin is out for primary prevention of cardiovascular disease - CON.

Speaker: Professor C. Patrono (Rome, IT)

Thumbnail

Aspirin is out for primary prevention of cardiovascular disease - Discussion.

Thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - PRO.

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.

Speaker: Doctor T. Cuisset (Marseille, FR)

Thumbnail

Access the full session

Controversies in antithrombotic treatment for primary and secondary prevention

Speakers: Professor J. Armitage, Professor C. Patrono, Doctor J. Eikelboom, Doctor T. Cuisset
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk